Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Agranulocytosis caused by captopril].

P Assyag, A Koenig, H Fass

    Annales De Cardiologie Et D'Angeiologie
    |February 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Determinants of virological outcomes in kidney transplant recipients treated with maribavir for refractory cytomegalovirus infection.

    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
    Same author

    Ivory vs. osseous ivory substitutes-Non-invasive diffractometric discrimination.

    Forensic science international·2020
    Same author

    Infant carrying in a polygynous group of common marmosets (Callithrix jacchus).

    American journal of primatology·2020
    Same author

    Infant survival and number of helpers in captive groups of common marmosets (Callithrix jacchus).

    American journal of primatology·2020
    Same author

    Group size, composition, and reproductive success in wild common marmosets (Callithrix jacchus).

    American journal of primatology·2020
    Same author

    Thermomechanical method for cement extraction in revision arthroplasty.

    European journal of orthopaedic surgery & traumatology : orthopedie traumatologie·2017

    Captopril can cause agranulocytosis, a severe drop in white blood cells, even in patients without risk factors. Careful monitoring and dosage adjustments are crucial when prescribing this hypertension medication.

    Area of Science:

    • Pharmacology
    • Hematology
    • Cardiology

    Background:

    • Captopril is an effective treatment for hypertension and heart failure.
    • While generally safe, captopril can cause severe side effects like agranulocytosis.
    • Agranulocytosis risk increases with renal insufficiency, collagen diseases, or leucopenic medications.

    Observation:

    • This case details agranulocytosis secondary to captopril in a patient with heart failure.
    • The patient had no pre-existing risk factors for this complication.
    • The adverse event did not appear to be dose-related.

    Findings:

    • Captopril-induced agranulocytosis can occur in patients without typical risk factors.
    • The exact mechanism of captopril-induced agranulocytosis remains unclear.

    Related Experiment Videos

  • This case highlights the potential for severe hematologic reactions.

    • Implications:

    • Prescribing captopril requires caution, especially in patients with renal insufficiency or collagen diseases.
    • Avoid co-administration with leucopenic medications.
    • Individualized hematologic monitoring is essential for patients on captopril.